| Literature DB >> 24205273 |
Cristina Blasco-Lafarga1, Ignacio Martínez-Navarro, Manuel Mateo-March.
Abstract
Little research exists concerning Heart Rate (HR) Variability (HRV) following supramaximal efforts focused on upper-body explosive strength-endurance. Since they may be very demanding, it seems of interest to analyse the relationship among performance, lactate and HR dynamics (i.e. HR, HRV and complexity) following them; as well as to know how baseline cardiac autonomic modulation mediates these relationships. The present study aimed to analyse associations between baseline and post-exercise HR dynamics following a supramaximal Judo test, and their relationship with lactate, in a sample of 22 highly-trained male judoists (20.70±4.56 years). A large association between the increase in HR from resting to exercise condition and performance suggests that individuals exerted a greater sympathetic response to achieve a better performance (Rating of Perceived Exertion: 20; post-exercise peak lactate: 11.57±2.24 mmol/L; 95.76±4.13 % of age-predicted HR(max)). Athletes with higher vagal modulation and lower sympathetic modulation at rest achieved both a significant larger ∆HR and a faster post-exercise lactate removal. A enhanced resting parasympathetic modulation might be therefore related to a further usage of autonomic resources and a better immediate metabolic recovery during supramaximal exertions. Furthermore, analyses of variance displayed a persistent increase in α₁ and a decrease in lnRMSSD along the 15 min of recovery, which are indicative of a diminished vagal modulation together with a sympathovagal balance leaning to sympathetic domination. Eventually, time-domain indices (lnRMSSD) showed no lactate correlations, while nonlinear indices (α₁ and lnSaEn) appeared to be moderate to strongly correlated with it, thus pointing to shared mechanisms between neuroautonomic and metabolic regulation.Entities:
Mesh:
Substances:
Year: 2013 PMID: 24205273 PMCID: PMC3799641 DOI: 10.1371/journal.pone.0078584
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Glossary of abbreviated terminology.
|
| |
|---|---|
| TEPU | Time-to-exhaustion Isometric Pull-Up |
| BSJTscore | Sum of T-scores for the seven skills involved in the |
| RPE | Rating of Perceived Exertion |
| Post1 | Recovery period comprised between 180 and 360 s after |
| Post2 | Recovery period comprised between 360 and 540 s after |
| Post3 | Recovery period comprised between 540 and 720 s after |
| Post3 | Recovery period comprised between 720 and 900 s after |
|
| |
| HRbaseline | Baseline heart rate |
| HRfinal | Heart rate at the end of |
| HRmax | Maximum heart rate achieved during |
| ΔHR | Difference between maximum heart rate achieved during the test and baseline heart rate |
| HRR1 | Difference between final heart rate and heart rate following 1 min of recovery |
| HRR2 | Difference between final heart rate and heart rate following 2 min of recovery |
| HRV | Heart Rate Variability |
| lnSDNN | Log-transformed Standard Deviation of all normal RR intervals |
| lnRMSSD | Log-transformed the Root-Mean-Square difference of successive normal RR intervals |
| lnHF | Log-transformed High Frequency power |
| lnLF | Log-transformed Low Frequency power |
| lnLFHF | Log-transformed Low Frequency to High Frequency ratio |
| α1 | Short-term fractal scaling exponent |
| lnSaEn | Log-transformed Sample Entropy |
| [La]n | Lactate concentration, where n= min of recovery (i.e. 1,3,5,10 & 15 min) |
| [La]peak | Lactate Peak concentration |
| [La]cle | Difference between [La]15 and [La]peak |
Figure 1Schematic view of the experimental protocol.
Descriptive data (mean ± SD) of resting HRV, performance, RPE, HR and lactate measures following BSJT.
|
|
| ||
|---|---|---|---|
|
| 20.70 ± 4.56 |
| 303.26 ± 42.94 |
|
| 22.84 ± 1.65 |
TE
| 28 ± 8.23 |
|
| 60.92 ± 11.78 |
| 20 ± 0 |
| ln | 4.16 ± 0.52 |
| 193.67 ± 9.57 |
| ln | 4.16 ± 0.66 | %HRmax | 95.76 ± 4.13 |
| ln | 7.38 ± 1.28 | ∆ | 133.31 ± 10.96 |
| ln | 7.27 ± 1.22 |
| 40.80 ± 12.13 |
| ln | 0.11 ± 1.14 |
| 56.66 ± 11.63 |
| α1 | 0.97 ± 0.39 | [La]peak (nmol/L) | 11.57 ± 2.24 |
| Ln | 0.42 ± 0.32 | [La]cle (mmol/L) | 1.91 ± 1.79 |
Abbreviations are explained in Table 1.
Correlations between performance and physiological responses to exercise.
|
|
|
|
|
|
| |
|---|---|---|---|---|---|---|
|
| - | 0.611 | -0.399 | -0.446 | 0.428 | 0.211 |
|
| 0.611 | - | -0.384 | -0.472 | 0.308 | 0.045 |
|
| -0.399 | -0.384 | - | 0.890 | -0.595 | -0.077 |
|
| -0.446 | -0.472 | 0.890 | - | -0.548 | -0.048 |
|
| 0.428 | 0.308 | -0.595 | -0.548 | - | 0.240 |
|
| 0.211 | 0.045 | -0.077 | -0.048 | 0.240 | - |
Abbreviations explained in Table 1. # p<0.1; *p<0.05; **p<0.01.
Pearson (R) and Partial correlations () either controlling for Age (HRbaseline), Age and RRi (α1, lnSaEn) or lnTP, Age and RRi (lnSDNN, lnRMSSD, lnLF, lnHF and lnLF/HF) between baseline HRV measures (rows), and performance and physiological responses to exercise (columns).
|
| ∆ |
|
| [La]peak
| [La]cle
| |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
| -0.229 |
| -0.617** |
| 0.646** |
| 0.607** |
| -0.472* |
| -0.093 |
|
| ln | 0.347 |
| 0.496 |
| -0.331 |
| -0.303 |
| 0.193 |
| 0.223 |
|
| ln | 0.519 |
| 0.667 |
| -0.476 |
| -0.457 |
| 0.378 |
| 0.292 |
|
| ln | 0.135 |
| 0.175 |
| -0.158 |
| -0.116 |
| 0.170 |
| 0.109 |
|
| ln | 0.468 |
| 0.649 |
| -0.286 |
| -0.275 |
| 0.393 |
| 0.397 |
|
| ln | -0.358 |
| -0.511 |
| 0.129 |
| 0.190 |
| -0.234 |
| -0.311 |
|
|
| -0.576 |
| -0.564 |
| 0.342 |
| 0.376 |
| -0.429 |
| -0.347 |
|
| ln | 0.236 |
| 0.215 |
| 0.021 |
| 0.032 |
| 0.393 |
| 0.283 |
|
Abbreviations explained in Table 1. # p<0.1; *p<0.05; **p<0.01.
Figure 2Relationship between BSJTscore (x-axis) and different variables (y-axis): [La]peak, ΔHR, lnRMSSD and α1.
Linear regression (R2) is included.
Partial correlations, controlling for age, between lactate concentration and lnRMSSD, lnSaEn and α1 during recovery.
The shadowed areas illustrate the time course of the relationships .
|
|
|
|
| |
|---|---|---|---|---|
|
| -0.147 | -0.121 | -0.168 | -0.153 |
|
| -0.132 | -0.066 | -0.135 | -0.105 |
|
| -0.129 | -0.066 | -0.107 | -0.129 |
|
| -0.128 | -0.122 | -0.165 | -0.143 |
|
| -0.435 | -0.338 | -0.442 | -0.112 |
|
| -0.500 | -0.363 | -0.444 | -0.059 |
|
| -0.491 | -0.451 | -0.525 | -0.293 |
|
| -0.649 | -0.479 | -0.688 | -0.293 |
|
| 0.528 | 0.552 | 0.624 | 0.301 |
|
| 0.284 | 0.291 | 0.486 | 0.197 |
|
| 0.213 | 0.324 | 0.373 | -0.033 |
|
| 0.285 | 0.220 | 0.505 | 0.179 |
Abbreviations explained in Table 1. # p<0.1; *p<0.05; **p<0.01.
Figure 3Heart Rate and lactate dynamics through the recovery period following BSJT.
Nonlinear (Figure 3a) and Linear (Figure 3b) indices in black lines; lactate in a grey line.
Under figure: * Significantly different from baseline condition (p<0.05 for α1; p<0.001 for lnRMSSD; p<0.01 for lactate); † Significantly different from [La]5. # Figure 3a: trend to significant difference from Post2 condition (p=0,056); # Figure 3b: Significantly different from Post2 condition (p<0.05).